A White Paper on Collagen Hydrolyzates and Ultrahydrolyzates: Potential Supplements to Support Joint Health in Osteoarthritis?
Ali MobasheriArmaghan MahmoudianUrsule KalvaityteIlona UzielieneChristina E LarderMichèle M IskandarStan KubowPaulo César HamdanCyro Scala DE AlmeidaLacey J FavazzoLuc J C van LoonPieter J EmansPérola Grinberg PlaplerMichael J ZuscikPublished in: Current rheumatology reports (2021)
This article reviews the relevant literature and serves as a White Paper on collagen hydrolyzates and ultrahydrolyzates as emerging supplements often advertised to support joint health in OA. Collagen hydrolyzates have demonstrated some evidence of efficacy in a handful of small scale clinical trials, but their ability to treat and reverse advanced joint disease remains highly speculative, as is the case for other nutritional supplements. The aim of this White Paper is to stimulate research and development of collagen-based supplements for patients with OA and other musculoskeletal diseases at academic and industrial levels. This White Paper does not make any treatment recommendations for OA patients in the clinical context, but simply aims to highlight opportunities for scientific innovation and interdisciplinary collaboration, which are crucial for the development of novel products and nutritional interventions based on the best available and published evidence.
Keyphrases
- knee osteoarthritis
- clinical trial
- public health
- end stage renal disease
- wound healing
- healthcare
- tissue engineering
- ejection fraction
- chronic kidney disease
- systematic review
- newly diagnosed
- health information
- rheumatoid arthritis
- peritoneal dialysis
- physical activity
- human health
- randomized controlled trial
- heavy metals
- patient reported
- patient reported outcomes
- climate change
- study protocol
- meta analyses
- medical students